Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,385,344
+$1,964,936 QoQ
Shares Held
2,573,447
+40.5% QoQ
Ownership
3.94%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#7
of 201 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. ARVN ranks #54 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in ARVN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,385,344 | 2,573,447 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,420,408 | 1,832,114 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,770,611 | 992,463 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $900,293 | 128,247 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,620,113 | 397,502 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,513,805 | 386,269 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,747,038 | 178,326 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,372,336 | 105,919 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $686,692 | 34,964 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,040,422 | 162,789 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,905,066 | 142,938 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $1,251,726 | 28,135 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $3,680,939 | 44,813 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $19,692,957 | 239,632 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $20,790,154 | 270,002 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $12,302,333 | 186,117 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $7,239,959 | 306,648 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $7,477,776 | 222,951 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,092,662 | 76,741 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||